Uterine Fibroid Embolization

Uterine fibroid embolization (UFE) is a minimally invasive procedure used to treat symptomatic uterine fibroids, which are non-cancerous growths in the uterus. It addresses symptoms such as heavy menstrual bleeding, pelvic pain, and pressure. UFE is typically indicated for women who seek an alternative to surgical options like hysterectomy. Interventional radiologists and vascular specialists commonly perform these procedures.

The clinical evidence for uterine fibroid embolization includes randomized controlled trials (RCTs), registry data, and case series. Outcomes typically measured include symptom relief, fibroid size reduction, and quality of life improvements. Evidence is strongest in demonstrating symptom relief and safety, while long-term outcomes and comparative effectiveness with surgical options are less robustly documented.

The uterine fibroid embolization device category includes various embolic agents and delivery systems. Key differentiating features include the size and material of embolic particles, which can affect the precision and control of the embolization process. Some devices are designed for specific anatomical considerations, such as vessel size and flow dynamics.

Uterine fibroid embolization is typically performed in a hospital or outpatient interventional radiology suite. Clinicians must consider patient selection, imaging requirements, and post-procedure care. Training involves understanding angiographic techniques and embolic material handling, with decision points including patient anatomy and symptomatology.